Press/Media
- 150 - 175 out of 279 results
Search results
-
Medical News Today: Using the immune system to combat addiction
Drew Kiraly
14/09/18
2 items of Media coverage
Press/Media
-
Immune system emerges as partner in opioid cravings fight
Erin S. Calipari & Drew Kiraly
5/09/18 → 8/09/18
2 items of Media coverage
Press/Media
-
Immune system that fights infection could join battle against opioid addiction
Drew Kiraly
7/09/18
1 item of Media coverage
Press/Media
-
Immune System: New Partner in Opioid Cravings Fight
Drew Kiraly
7/09/18
1 item of Media coverage
Press/Media
-
Immune system emerges as potential partner in opioid addiction fight
Erin S. Calipari & Drew Kiraly
6/09/18
1 item of Media coverage
Press/Media
-
Immune system emerges as potential partner in opioid cravings fight
Erin S. Calipari & Drew Kiraly
5/09/18 → 6/09/18
5 items of Media coverage
Press/Media
-
Immune system may join battle against opioid addiction
Drew Kiraly
6/09/18
1 item of Media coverage
Press/Media
-
IMMUNE SYSTEM EMERGES AS PARTNER IN OPIOID CRAVINGS FIGHT
Erin S. Calipari & Drew Kiraly
6/09/18
1 item of Media coverage
Press/Media
-
Immune System Emerges as Partner in Opioid Cravings Fight
Erin S. Calipari & Drew Kiraly
6/09/18
1 item of Media coverage
Press/Media
-
Your Immune System Could Aid Fight Against Opioid Addiction
Erin S. Calipari, Rebecca Hofford & Drew Kiraly
6/09/18
1 item of Media coverage
Press/Media
-
Analysis of shared heritability in common disorders of the brain
Sven S. Sandin, Silvia De Rubeis, Elodie Drapeau, Panagiotis Roussos, Dalila Pinto, Dan Stein, David Cohen & Laura Huckins
21/06/18
1 item of Media coverage
Press/Media
-
Life Fathers' antidepressant use doesn't worsen babies' health risks
Sven S. Sandin
20/06/18
1 item of Media coverage
Press/Media
-
Fathers' antidepressant use doesn't worsen babies' health risks
Sven S. Sandin
19/06/18 → 20/06/18
17 items of Media coverage
Press/Media
-
Fathers' Antidepressant Use Doesn't Worsen Babies' Health Risks
Sven S. Sandin
19/06/18
1 item of Media coverage
Press/Media
-
-
-AMO Pharma Announces Initiation of Clinical Trial conducted by Mount Sinai to Study AMO-01 in Treatment of Phelan-McDermid Syndrome
11/05/18
1 item of Media coverage
Press/Media
-
Seaver Autism Center for Research, Treatment at Mount Sinai Announces Clinical Trial of New Investigational Therapy for Phelan-McDermid Syndrome
7/05/18 → 8/05/18
2 items of Media coverage
Press/Media
-
United States: AMO Pharma Announces Initiation of Clinical Trial conducted by Mount Sinai to Study AMO-01 in Treatment of Phelan-McDermid Syndrome
8/05/18
1 item of Media coverage
Press/Media
-
AMO Pharma Announces Initiation of Clinical Trial conducted by Mount Sinai to Study AMO-01 in Treatment of Phelan-McDermid Syndrome
7/05/18 → 8/05/18
18 items of Media coverage
Press/Media
-
-
Alexander Kolevzon Listed a New Clinical Trial of AMO-01 to Treat Adolescents and Adults with Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
10/04/18
1 item of Media coverage
Press/Media
-
MBL Study Offers Insight Into Nerve Regeneration In People
16/03/18
1 item of Media coverage
Press/Media
-